Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProbeChem is a global supplier of high-quality biochemicals, specializing in small molecule inhibitors, agonists, antagonists, and chemical screening libraries for life science research. The company offers a comprehensive catalog of bioactive compounds targeting a wide range of signaling pathways, including kinases, GPCRs, and epigenetic regulators. ProbeChem supports drug discovery and development by providing high-purity reagents, PROTACs, and custom synthesis services to academic and industrial researchers. Their products are widely utilized in studies related to oncology, immunology, and neuroscience, facilitating the identification of new therapeutic targets and the validation of biological mechanisms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProbeChem.